LGALS13
LGALS13 (galectin 13, also known as PP13 and PLAC8) is a soluble beta-galactoside-binding lectin of the galectin group. It binds lactose, is a strong inducer of T-cell apoptosis and has been described as an activator of ferroptosis. Browse Assay Genie's current range of LGALS13 research reagents below, or read on for the biology behind the target.
LGALS13 is a soluble lectin that binds beta-galactoside and lactose. It is a strong inducer of T-cell apoptosis and shows hemagglutinating activity towards chicken erythrocytes. More recently it has been described as an activator of ferroptosis: the protein is secreted by ferroptotic cells and acts by reducing the localisation of SLC7A11 at the plasma membrane.
The LGALS13 gene encodes a protein that forms a dimer of two identical subunits held together by disulfide bonds. Its structure resembles that of several members of the beta-galactoside-binding S-type lectin family, and HGNC places it in the galectin gene group. UniProt records the protein in the cytoplasm, the nuclear matrix and in secreted form. The NCBI Gene summary also reports that the protein has lysophospholipase activity, an enzyme class that acts on biological membranes to regulate lysophospholipids.
The protein is known as galectin 13, galactoside-binding soluble lectin 13, PP13 and PLAC8, and the previous HGNC name was lectin, galactoside-binding, soluble, 13. Researchers studying LGALS13 often work alongside other galectin family members, and may look for an LGALS13 antibody, an LGALS13 ELISA kit or recombinant LGALS13 protein to investigate its roles in lectin biology, T-cell apoptosis and ferroptosis.
LGALS13 binds beta-galactoside and lactose and resembles S-type lectins, making it a useful member of the galectin group for carbohydrate-binding studies.
LGALS13 is annotated as a strong inducer of T-cell apoptosis, so it is relevant to research on how lectins regulate T-cell survival.
Secreted by ferroptotic cells, LGALS13 activates ferroptosis by reducing SLC7A11 localisation at the plasma membrane.
The NCBI Gene summary reports lysophospholipase activity for LGALS13, linking it to the regulation of lysophospholipids in biological membranes.
LGALS13 binds beta-galactoside and lactose, strongly induces T-cell apoptosis and agglutinates chicken erythrocytes. It also activates ferroptosis: it is secreted by ferroptotic cells and reduces SLC7A11 localisation at the plasma membrane. NCBI Gene additionally reports lysophospholipase activity.
LGALS13 is the HGNC symbol for galectin 13. Aliases and previous symbols include PP13 and PLAC8, and UniProt names the protein galactoside-binding soluble lectin 13. The earlier HGNC name was lectin, galactoside-binding, soluble, 13. Searching under any of these names may help locate relevant literature.
Yes. HGNC classifies LGALS13 in the galectin gene group, and the NCBI Gene summary notes structural similarity to several members of the beta-galactoside-binding S-type lectin family. Related genes with their own pages include LGALS12, LGALS14, LGALS2, LGALS4 and LGALS8. Check the datasheet of any product for its validated reactivity.
Other galectin family members and related lectins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UHV8; product specifications from Assay Genie datasheets.